Get started
Author

Darcy Hamill

Mesothelin: An Immunotherapeutic Target beyond Solid Tumors
2022 · Joshua R. Faust, Darcy Hamill, et al. · Cancers · 100
PDF
Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies
2021 · Anilkumar Gopalakrishnapillai, Colin E. Correnti, et al. · Cancers · 13
PDF
Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1
2020 · Michael D. Kinnaman, Darcy Hamill, et al. · JCO Precision Oncology · 4
Mesothelin Expression Is Associated with Extramedullary Disease and Promotes In Vivo Leukemic Growth in Acute Myeloid Leukemia
2020 · Katherine Tarlock, Todd A. Alonzo, et al. · Blood · 3
Robust Donor Chimerism and Engraftment Following Familial Haploidentical (FHI) (CD34 Enriched and T-Cell Addback) Allogeneic Stem Cell Transplantation in Patients with High Risk Sickle Cell Disease (SCD)
2016 · Darcy Hamill, Lee Ann Baxter-Lowe, et al. · Transplantation and Cellular Therapy · 2
Apixaban for the treatment of venous thromboembolic events in paediatric patients: an open-label, multicentre, randomised, controlled descriptive trial
2026 · Leonardo R Brandão, Leonardo R Brandão, et al. · The Lancet Haematology · 1
Mesothelin promotes acute myeloid leukemia progression through LYN-dependent signaling
2026 · Joshua R. Faust, Darcy Hamill, et al. · Journal of Biological Chemistry · 1
An Insight into the Role of Mesothelin in Pediatric Acute Myeloid Leukemia
2022 · Joshua R. Faust, Darcy Hamill, et al. · The FASEB Journal · 1
Contemporary Epidemiology of Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome (VOD) in Pediatric Patients Transplanted for Acute Leukemia: Association with Antibody-Drug Conjugate Medications
2026 · Caitlin W. Elgarten, Troy C. Quigg, et al. · Transplantation and Cellular Therapy
Optimal therapy for pediatric B-ALL in first relapse: Comparative effectiveness of blinatumomab to hematopoietic cell transplantation versus CD19 CAR T cell therapy
2025 · Regina Myers, Yimei Li, et al. · Blood
Disparate post-relapse survival outcomes by race/ethnicity for children with B-cell acute lymphoblastic leukemia: An analysis from the recall-1 study
2025 · Abigale Berry, Caitlin Elgarten, et al. · Blood
Survival after first relapse of pediatric B-ALL differs by insurance type: A real-world analysis from the recall-1 study
2025 · Katherine Lind, Abigale Berry, et al. · Blood
PDF
T Cell Engaging Bispecific Antibodies Produce Durable Response in Mesothelin-Positive Patient-Derived Xenograft Models of Pediatric AML
2021 · Anilkumar Gopalakrishnapillai, Colin Correnti, et al. · Blood
Massive splenomegaly in a 6-year-old girl
2019 · Jennifer Bleznak, Ashley Anttila, et al.
Abstract LB-322: Identification of a novel fusion protein SPTAN1-ABL1 in a child with T-cell acute lymphoblastic leukemia: Functional characterization and therapeutic implications
2019 · Anilkumar Gopalakrisnapillai, Erin Crowgey, et al. · Cancer Research
Abstract LB-322: Identification of a novel fusion protein SPTAN1-ABL1 in a child with T-cell acute lymphoblastic leukemia: Functional characterization and therapeutic implications
2019 · Anilkumar Gopalakrisnapillai, Erin Crowgey, et al. · Tumor Biology
Works count: 16
Citation count: 125
H-index: 3
I10-index: 2
Year
Topic
Type